Related Experiment Video
Updated: Aug 14, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
Published on: January 8, 2015
Lessons from anticancer research might provide new insights into mechanisms of hormone action
1College of Pharmacy, University of Cincinnati Medical Center, 3223 Eden Ave, PO Box 670004, Cincinnati, OH 45267-0004, USA. Arthur.Buckley@uc.edu
Abstract:
The extent to which specific anticancer drugs induce apoptosis in tumors frequently predicts the success of chemotherapy for a particular type of cancer. Recent results from experiments designed to evaluate drug-induced apoptosis in colon cancer cells revealed that the levels of BCL-2-related apoptotic suppressor proteins were dramatically reduced compared with those of pro-apoptotic proteins. In the case of nonsteroidal anti-inflammatory drugs, this might be a consequence of inhibition of the cyclooxygenase-mediated production of prostaglandins.
Insights
Chemotherapy success in colon cancer hinges on drug-induced apoptosis. Key suppressor proteins like BCL-2 were reduced, potentially due to prostaglandin inhibition by anti-inflammatory drugs.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Chemotherapy efficacy often correlates with the induction of tumor cell apoptosis.
- Understanding the molecular mechanisms of drug-induced apoptosis is crucial for cancer treatment.
- BCL-2 family proteins play a critical role in regulating apoptosis.
Purpose of the Study:
- To investigate the levels of apoptosis-regulating proteins in colon cancer cells treated with anticancer drugs.
- To explore the potential role of prostaglandin production in drug-induced apoptosis.
Main Methods:
- Experiments were conducted on colon cancer cells.
- Levels of BCL-2-related apoptotic suppressor proteins and pro-apoptotic proteins were measured.
- The role of cyclooxygenase-mediated prostaglandin production was considered.
Main Results:
- Anticancer drugs significantly reduced BCL-2-related apoptotic suppressor proteins compared to pro-apoptotic proteins in colon cancer cells.
- This reduction in suppressor proteins suggests an increased susceptibility to apoptosis.
- Nonsteroidal anti-inflammatory drugs may contribute to this effect by inhibiting prostaglandin synthesis.
Conclusions:
- The balance of BCL-2-related proteins is a critical determinant of chemotherapy response in colon cancer.
- Inhibition of prostaglandin production by nonsteroidal anti-inflammatory drugs might enhance chemotherapy effectiveness by promoting apoptosis.
- Further research is warranted to explore therapeutic strategies targeting these pathways.
Related Concept Videos
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

